相似文献
1
Screening and treatment of infections caused by resistant enterococci.
Antimicrob Agents Chemother. 1991 Feb;35(2):215-9. doi: 10.1128/AAC.35.2.215.
2
[Vancomycin resistance in Gram-positive bacteria].
Enferm Infecc Microbiol Clin. 1991 Feb;9(2):69-71.
3
[Current problems of antibiotic resistance in the treatment of pediatric patients].
Antibiot Khimioter. 1998;43(4):43-9.
4
Antibiotic resistance--experience in a tertiary care hospital in south India.
J Assoc Physicians India. 2010 Dec;58 Suppl:18-22.
5
Resistance patterns among nosocomial pathogens: trends over the past few years.
Chest. 2001 Feb;119(2 Suppl):397S-404S. doi: 10.1378/chest.119.2_suppl.397s.
6
Antibiotic resistance: how it arises, the current position and strategies for the future.
Nurs Times. 2009;105(36):20-3.
7
Comparative antibiotic susceptibilities of anaerobes associated with infections of the female reproductive tract.
Clin Infect Dis. 1993 Jun;16 Suppl 4:S349-52. doi: 10.1093/clinids/16.supplement_4.s349.
8
Antimicrobial resistance--pharmacological solutions.
Infection. 1999;27 Suppl 2:S32-4. doi: 10.1007/BF02561668.
9
[Sensitivity of bacteria to therapeutic drugs (Zurich 1996)].
Praxis (Bern 1994). 1998 Mar 18;87(12):403-12.
10
Bacterial pathogens isolated from patients with bloodstream infection: frequencies of occurrence and antimicrobial susceptibility patterns from the SENTRY antimicrobial surveillance program (United States and Canada, 1997).
Antimicrob Agents Chemother. 1998 Jul;42(7):1762-70. doi: 10.1128/AAC.42.7.1762.
引用本文的文献
1
Phenotypic and Genotypic Analysis of Bacterial Pathogens Recovered from Patients Diagnosed with Fever of Unknown Origin in Egypt.
Antibiotics (Basel). 2023 Aug 7;12(8):1294. doi: 10.3390/antibiotics12081294.
2
High-level Aminoglycoside Resistance and Reduced Susceptibility to Vancomycin in Nosocomial Enterococci.
J Glob Infect Dis. 2010 Sep;2(3):231-5. doi: 10.4103/0974-777X.68534.
3
Vancomycin-resistant enterococci.
Clin Microbiol Rev. 2000 Oct;13(4):686-707. doi: 10.1128/CMR.13.4.686.
4
Resistant enterococci--mechanisms, laboratory detection and control in hospitals.
J Clin Pathol. 1996 Sep;49(9):700-3. doi: 10.1136/jcp.49.9.700.
5
Gastrointestinal tract colonization with vancomycin-resistant Enterococcus faecium in an animal model.
Antimicrob Agents Chemother. 1996 Jun;40(6):1526-30. doi: 10.1128/AAC.40.6.1526.
6
Current perspectives on glycopeptide resistance.
Clin Microbiol Rev. 1995 Oct;8(4):585-615. doi: 10.1128/CMR.8.4.585.
7
Infections due to antibiotic-resistant gram-positive cocci.
J Gen Intern Med. 1993 Nov;8(11):626-34. doi: 10.1007/BF02599723.
8
Novel antibiotic regimens against Enterococcus faecium resistant to ampicillin, vancomycin, and gentamicin.
Antimicrob Agents Chemother. 1993 Sep;37(9):1904-8. doi: 10.1128/AAC.37.9.1904.
9
Anti-infective treatment in intensive care: the role of glycopeptides.
Intensive Care Med. 1994 Nov;20 Suppl 4:S17-22. doi: 10.1007/BF01713978.
10
Recovery of vancomycin-resistant gram-positive cocci from pediatric liver transplant recipients.
J Clin Microbiol. 1991 Nov;29(11):2503-6. doi: 10.1128/jcm.29.11.2503-2506.1991.
本文引用的文献
1
Antibiotic therapy of bacterial endocarditis. VI. Subacute enterococcal endocarditis; clinical, pathologic and therapeutic consideration of 33 cases.
Circulation. 1954 Aug;10(2):173-94. doi: 10.1161/01.cir.10.2.173.
2
Synergy of penicillin and decreasing concentration of aminoglycosides against enterococci from patients with infective endocarditis.
Antimicrob Agents Chemother. 1980 Dec;18(6):944-7. doi: 10.1128/AAC.18.6.944.
3
Influence of gentamicin dose size on the efficacies of combinations of gentamicin and penicillin in experimental streptomycin-resistant enterococcal endocarditis.
Antimicrob Agents Chemother. 1982 Dec;22(6):972-5. doi: 10.1128/AAC.22.6.972.
4
Enterococci. Biologic and epidemiologic characteristics and in vitro susceptibility.
Arch Intern Med. 1982 Oct 25;142(11):2006-9. doi: 10.1001/archinte.142.11.2006.
5
Susceptibility of enterococci and Listeria monocytogenes to N-Formimidoyl thienamycin alone and in combination with an aminoglycoside.
Antimicrob Agents Chemother. 1981 May;19(5):789-93. doi: 10.1128/AAC.19.5.789.
6
Methodological variation in antibiotic synergy tests against enterococci.
J Clin Microbiol. 1981 Jan;13(1):73-5. doi: 10.1128/jcm.13.1.73-75.1981.
7
Synergy of imipenem or penicillin G and aminoglycosides against enterococci isolated from patients with infective endocarditis.
Antimicrob Agents Chemother. 1984 Dec;26(6):909-12. doi: 10.1128/AAC.26.6.909.
8
Emergence of Streptococcus faecalis isolates with high-level resistance to multiple aminocyclitol aminoglycosides.
Diagn Microbiol Infect Dis. 1984 Jun;2(3):171-7. doi: 10.1016/0732-8893(84)90027-0.
9
Treatment of streptomycin-susceptible and streptomycin-resistant enterococcal endocarditis.
Ann Intern Med. 1984 Jun;100(6):816-23. doi: 10.7326/0003-4819-100-6-816.
10
Imipenem therapy of experimental Staphylococcus aureus and Streptococcus faecalis endocarditis.
J Antimicrob Chemother. 1983 Dec;12 Suppl D:65-78. doi: 10.1093/jac/12.suppl_d.65.
Zotero 插件